Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1623-1629

  Chandra, Peeyush ^a   Gaur, Ajit ^a   Varma, Shambhu ^b  

^a Chandra Eye Research Institute   (India)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Caffeine; Intraocular pressure; Ocular hypertension; Open angle glaucoma

Indexed keywords

CAFFEINE; EYE DROPS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG INSTILLATION; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PRESSURE MEASUREMENT; TONOMETER; WELLBEING;

EID: 84856197136     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S25291     Document Type: Article

References (78)

1. Barone JJ, Robert HR. Caffeine consumption. Food Chem Toxicol. 1996;34:119-129.
2. wiseGeek. How much caffeine is consumed by the average person? [Web page on the Internet.] Sparks, NV: wiseGeek; nd. Available from: http://www.wisegeek.com/how-much-caffeine-is-consumed-by-the-average-person.htm. Accessed September 13, 2011.
3. Energy Fiend. Caffeine: consumption by country [web page on the Internet]. Energy Fiend; nd [updated August 18, 2011]. Available from: http://www.energyfiend.com/caffeine-what-the-world-drinks. Accessed September 13, 2011.
4. Serafin WE. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gillman A, editors. Goodman and Gillman's Pharmacological Basis of Therapeutics. 9th edition. New York: McGraw Hill; 1996: 673-679.
5. Arnaud MJ. The pharmacology of caffeine. Prog Drug Res. 1987;31: 273-313.
6. Wilson DF. Effect of caffeine on neuromuscular transmission in rats. Am J Physiol. 1973;225(4):862-865.
7. Daly JW, Burns RF, Snyder SH. Adenosine receptor in the central nervous system; Relationship to the central actions of methylxanthines. Life Sci. 1981;28(19):2083-2097.
8. Dunwiddie TV. Interactions between the effects of adenosine and calcium on synaptic responses in rat hippocampus in vitro. J Physiol. 1984;350:545-559.
9. Morgan MD, Vestal RE. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry. Life Sci. 1989;45:2025-2039.
10. Pedata F, Giovanelli L, De Samo P, Pepeu B. Effect of adenosine derivatives and caffeine on acetylcholine release from the brain synaptosomes: Interaction with muscarinic autoregulatory mechanisms. J Neurochem. 1986;46(5):1593-1598.
11. Solinas M, Ferre S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 2002;22(15):6321-6324.
12. Degubareff T, Sleator W Jr. Effects of caffeine on t mammalian atrial muscle and its interaction with adenosine and calcium. J Pharmacol Exp Ther. 1965;148:202-214.
13. Blinks JO, Olson CB, Jewell BR, Braveny P. Influence of caffeine and other methyl xanthines in the mechanical properties of isolated mammalian heart muscle. Circ Res. 1972;30(4):367-392.
14. Dobemeyer JJ, Stein RA, Leier RA, Greenberg R, Schaal SF. The arrythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308(14):814-816.
15. Ogawa Y, Ebashi S. Ca-Releasing action of βγ-methylene adenosine triphosphate on fragmented sarcoplasmic reticulum. J Biochem. 1976;80(5):1149-1157.
16. Rousseau E, Ladine J, Liu QY, Meissner G. Activation of Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys. 1988;267(1):75-86.
17. Bhat MB, Zhao J, Zang W, et al. Caffeine-induced release of intra-cellular Ca2+ from Chinese hamster ovary cells expressing skeletal muscle ryanodine receptor. Effects on full length carboxyl-terminal portion of Ca2+ release channels. J Gen Physiol. 1997;110(6):749-762.
18. Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am J Physiol. 1994;226(6 Pt 1): C1485-C1504.
19. Echeverri D, Montes FR, Cabrera M, Galan A, Prieto A. Caffeine's vascular mechanisms of action. Int J Vasc Med. 2010;2010:834060.
20. Acheson KH, Zahorska-Mickiewicz B, Pittet P, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980;33(5):989-997.
21. Bauer J, Maier K, Linderkamp O, Hentschel R. Effects of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001;107(4):660-663.
22. Belza A, Toubro S, Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr. 2009;63(1):57-64.
23. Yeo SE, Jentjens RL, Wallis GA, Jeukendrup AE. Caffeine increases exogenous carbohydrate oxidation during exercise. J Appl Physiol. 2005;99(3):844-850.
24. Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland WW, Newman EV. Effect of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol. 1970;6(6):597-603.
25. Shi X, Dalal NS, Jain AC. Antioxidant behavior of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol. 1991;29(1):1-6.
26. Stadler RH, Fay LB. Antioxidative reactions of caffeine: formation of 8-oxocaffeine (1,3,7 trimethyl uric acid) in coffee subjected to oxidative stress. J Agric Food Chem. 1995;43:1332-1338.
27. Devasagayam TP, Kamat JP, Mohan H, Kesavan PC. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta. Bio membranes. 1996;1282(1): 63-70.
28. Stadler RH, Richoz J, Turesky RJ, Welti DH, Fay LB. Oxidation of caffeine and related methylxanthines in ascorbate and polyphenol-driven Fenton-type oxidations. Free Radic Res. 1996;24(3): 225-240.
29. Varma SD, Kumar S, Richards RD. Light-induced damage to ocular lens cation pump: prevention by vitamin C. Proc Natl Acad Sci U S A. 1979;76(7):3504-3506.
30. Chung WG, Cha YN. Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes. Biochem Biophys Res Commun. 1997;235(3): 685-688.
31. Dalmazio I, Santos LS, Lopes RP, Eberlin MN, Augusti R. Advanced oxidation of caffeine in water: On-line and real-time monitoring by electrospray ionization mass spectrometry. Environ Sci Technol. 2005;39(16):5982-5988.
32. Telo JP, Vieira AJ. Mechanism of free radical oxidation of caffeine in aqueous solution. J Chem Soc Perkin Trans. 1997;2:1755-1757.
33. Varma SD, Kovtun S, Hegde K. Role of ultraviolet irradiation and oxidative stress in cataract formation: medical prevention by nutritional antioxidants and metabolic agonists. Eye Contact Lens. 2011;37(4):233-245.
34. Higginbotham EJ, Kilimanjaro HA, Wilensky JT, Batenhorst RL, Hermann D. The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology. 1989;96(5):624-626.
35. Avisar R, Avisa E, Weinberger D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother. 2002;36(6):992-995.
36. Leydhecker W. Glaukom, ein Handbuch [Handbook of Glaucoma]. Berlin: Springer-Verlag; 1960.
37. Peczon JD, Grant WM. Sedatives, stimulants, and intraocular pressure in glaucoma. Arch Ophthalmol. 1964;72:178-188.
38. Chandrasekaran S, Rochtchina E, Mitchell P. Effect of caffeine on intraocular pressure: The Blue Mountains Eye Study. J Glaucoma. 2005;14(6):504-507.
39. Jim and Looker [Internet pseudonyms]. Caffeine and ocular pressure? MedKB.com [forum on the Internet]. MedKB; November 2003. Available from: http://www.medkb.com/Uwe/Forum.aspx/glaucoma/97/Caffiene-and-occular-pressure. Accessed September 13, 2011.
40. Wilensky JT. Glaucoma. Eye Facts [website on the Internet]. Chicago, IL: University of Illinois Department of Ophthalmology and Visual Sciences; November 10, 2010. Available from: http://www.uic.edu/com/eye/LearningAboutVision/EyeFacts/Glaucoma.shtml. Accessed September 13, 2011.
41. Leydhecker W. The water-drinking test. British J Ophthalmol. 1950;34(8):457-479.
42. Buckingham T, Young R. The rise and fall of intra-ocular pressure; the influence of physiological factors. Ophthalmic Physiol Opt. 1986;6(1):95-99.
43. Drance SM. Studies with applanation water tests. Arch Ophthalmol. 1963;69:39-43.
44. Moura MA, Rodrigues LO, Waisberg Y, De Almeida HG, Silami-Garcia E. Effects of submaximal exercise with water ingestion on intraocular pressure in healthy human males. Braz J Med Biol Res. 2002;35(1):121-125.
45. Armaly MF, Sayegh RE. Water-drinking test. II. The effect of age on tonometric and tonographic measures. Arch Ophthalmol. 1970;83(2):176-181.
46. Alimuddin M. Normal intra-ocular pressure. Br J Ophthalmol. 1956;40(6): 366-372.
47. Agarwal LP, Sharma CK. Two provocative tests for glaucoma. Br J Ophthalmol. 1955;37(6):330-335.
48. Kang JH, Willet WC, Rosner BA, Hankinson SE, Pasquale LR. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci. 2008;49(5):1924-1931.
49. Illy E. The complexity of coffee. Scientific American. 2002;286(6): 86-91.
50. Adams BA, Brubaker RF. Caffeine has no clinically significant effect on aqueous humor flow in the normal human eye. Ophthalmology. 1990;97(8):1030-1031.
51. Maia L, de Mendonça A. Does caffeine intake protect from Alzheimer's disease? Eur J Neurol. 2002;9(4):377-382.
52. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's Disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445-453.
53. Institute of Holistic Nutrition. Caffeine anyone? Available at:http://www.sciencedaily.com/releases/2009/01/090114200005.htm.
54. Ritchie K, Carriere I, de Mendonca A, et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology. 2007;69(6):536-545.
55. Ross GW, Abbott RD, Petrovich H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283(20):2674-2679.
56. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease. Neurology. 2000;55(9):1350-1358.
57. Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology. 2005;110(1-2):45-52.
58. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D. Coffee consumption and cognitive function among older adults. Am J Epidemiol. 2002;156(9):842-850.
59. Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140(1):1-8.
60. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169(22):2053-2063.
61. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006;166(11):1190-1195.
62. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol. 2007;26(1):1-8.
63. Inoue M, Yoshimi I, Sobue T, Tsugane S. JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005;97(4): 293-300.
64. Rodriguez T, Altieri A, Chatenoud L, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 2004;40(2): 207-213.
65. Tavani A, Bertuzzi M, Talamini R, et al. Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol. 2003;39(7):695-700.
66. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(3):712-716.
67. Ganmaa D, Willett WC, Li TY, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer. 2008;122(9):2071-2076.
68. Flatow J, Wilson K. can coffee lower the risk of prostate cancer [Tran-script.] National Public Radio. December 11, 2009. Available at: http://www.npr.org/templates/story/story.php?storyId=121343438. Accessed September 21, 2011.
69. Cromie W. Coffee gets cleared of blood pressure risk. Harvard Gazette. Nov 2005;10:2006. Available at: http://www.news.harvard.edu/gazette/2005/11.10/06-coffee.html.
70. Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006;113(17):2045-2053.
71. Rizzi GP. Formation of sulfur-containing volatiles under coffee roasting. In: Parliament TH, Ho CT, Schieberle. Caffeinated Beverages: Health Benefits, Physiological Effects, and Chemistry. ACS Symposium Series, Vol 754. Washington, DC: American Chemical Society; 2000:210-215.
72. Quarta B, Anese M. Furfurals removal from roasted coffee powder by vacuum treatment. Food Chem. 2011;130:610-614.
73. Grant WM. Toxicology of the Eye. 2nd ed. Springfield Illinois: Charles C Thomas; 1974:590, 502.
74. Varma SD, Hegde KR. Prevention of oxidative damage to lens by caffeine. J Ocul Pharmacol Ther. 2010;26(1):73-77.
75. Varma SD, Hegde KR. Kynurenine-induced photo oxidative damage to lens in vitro: protective effect of caffeine. Mol Cell Biochem. 2010;340(1-2):49-54.
76. Wang L, Lu L. Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48(2):652-660.
77. Baselt R. Disposition of Toxic Drugs and Chemicals in man. (9th ed.) Seal Beach, CA: Biomedical Publications; 2011.
78. Varma SD, Kovtun S, Hegde K. Effectiveness of topical caffeine in cataract prevention: studies with galactose cataract. Mol Vis. 2010;16:2626-2633.